1. 314.2: MTOR Inhibitors Promote Highly Functional T Cell Immunity in Kidney Transplant Recipients Vaccinated Against COVID-19. (13th September 2022) Authors: Perkins, Griffith; Tunbridge, Matthew; Salehi, Tania; Sheng Chai, Cheng; Hope, Christopher M; Garcia-Valtanen, Pablo; Singer, Julian J; Hurtado, Plinio R; Turville, Stuart; Hissaria, Pravin; Grubor-Bauk, Branka; Barry, Simon C; Chadban, Steven J; Coates AO, Toby Journal: Transplantation Issue: Volume 106: Supplement 9S (2022) Page Start: S223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 314.2: MTOR Inhibitors Promote Highly Functional T Cell Immunity in Kidney Transplant Recipients Vaccinated Against COVID-19. (13th September 2022) Authors: Perkins, Griffith; Tunbridge, Matthew; Salehi, Tania; Sheng Chai, Cheng; Hope, Christopher M; Garcia-Valtanen, Pablo; Singer, Julian J; Hurtado, Plinio R; Turville, Stuart; Hissaria, Pravin; Grubor-Bauk, Branka; Barry, Simon C; Chadban, Steven J; Coates AO, Toby Journal: Transplantation Issue: Volume 106: Supplement 9S (2022) Page Start: S223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Analysis and dissociation of anti‐HIV effects of shRNA to CCR5 and the fusion inhibitor C46. (25th March 2018) Authors: Ledger, Scott; Howe, Annett; Turville, Stuart; Aggarwal, Anupriya; Savkovic, Borislav; Ong, Andrew; Wolstein, Orit; Boyd, Maureen; Millington, Michelle; Gorry, Paul R.; Murray, John M.; Symonds, Geoff Journal: Journal of gene medicine Issue: Volume 20:Number 2/3(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Antiviral cyclic peptides targeting the main protease of SARS-CoV-2. Issue 13 (10th March 2022) Authors: Johansen-Leete, Jason; Ullrich, Sven; Fry, Sarah E.; Frkic, Rebecca; Bedding, Max J.; Aggarwal, Anupriya; Ashhurst, Anneliese S.; Ekanayake, Kasuni B.; Mahawaththa, Mithun C.; Sasi, Vishnu M.; Luedtke, Stephanie; Ford, Daniel J.; O'Donoghue, Anthony J.; Passioura, Toby; Larance, Mark; Otting, Got... Journal: Chemical science Issue: Volume 13:Issue 13(2022) Page Start: 3826 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Blocking of HIV entry through CD44–hyaluronic acid interactions. Issue 9 (26th August 2014) Authors: Turville, Stuart Journal: Immunology and cell biology Issue: Volume 92:Issue 9(2014) Page Start: 735 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. COVID‐19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B‐lymphocytosis; humoural and cellular immunity. (5th January 2022) Authors: Shen, Yandong; Freeman, Jane A.; Holland, Juliette; Solterbeck, Ann; Naidu, Kartik; Soosapilla, Asha; Downe, Paul; Tang, Catherine; Kerridge, Ian; Wallman, Lucinda; Van Bilsen, Nenna; Milogiannakis, Vanessa; Akerman, Anouschka; Martins Costa Gomes, Gabriela; Sandgren, Kerrie; Cunningham, Anthony&... Journal: British journal of haematology Issue: Volume 197:Number 1(2022) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection. Issue 40 (24th September 2021) Authors: Li, Lei; Honda-Okubo, Yoshikazu; Huang, Ying; Jang, Hyesun; Carlock, Michael A.; Baldwin, Jeremy; Piplani, Sakshi; Bebin-Blackwell, Anne G.; Forgacs, David; Sakamoto, Kaori; Stella, Alberto; Turville, Stuart; Chataway, Tim; Colella, Alex; Triccas, Jamie; Ross, Ted M.; Petrovsky, Nikolai Journal: Vaccine Issue: Volume 39:Issue 40(2021) Page Start: 5940 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti‐spike neutralizing IgG to SARS‐CoV‐2 variants, but preserved antigen‐specific T cell responses. Issue 1 (9th June 2022) Authors: Beaton, Brendan; Sasson, Sarah C.; Rankin, Katherine; Raedemaeker, Juliette; Wong, Alexander; Hastak, Priyanka; Phetsouphanh, Chansavath; Warden, Andrew; Klemm, Vera; Munier, C. Mee Ling; Hoppe, Alexandra Carey; Tea, Fiona; Pillay, Aleha; Stella, Alberto Ospina; Aggarwal, Anupriya; Lavee, Orly; C... Journal: American journal of hematology Issue: Volume 98:Issue 1(2023) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Persistent high‐level shedding of cultivable SARS‐CoV‐2 Delta virus 33 days after onset of COVID‐19 in a hospitalized patient with pneumonia. Issue 9 (14th May 2022) Authors: Kim, Ki Wook; Wang, Xinye; Adhikari, Anurag; Yeang, Malinna; Jenkins, Frances; Naing, Zin; Walker, Gregory J.; Foster, Charles S. P.; Stelzer‐Braid, Sacha; Deveson, Ira; Craig, Maria E.; Tedla, Nicodemus; Bull, Rowena A.; Martinello, Marianne; Pinto, Angie N.; Chan, Raymond; Turville, Stuart; Raw... Journal: Journal of medical virology Issue: Volume 94:Issue 9(2022) Page Start: 4043 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies. Issue 1 (1st January 2021) Authors: Rouet, Romain; Mazigi, Ohan; Walker, Gregory J.; Langley, David B.; Sobti, Meghna; Schofield, Peter; Lenthall, Helen; Jackson, Jennifer; Ubiparipovic, Stephanie; Henry, Jake Y.; Abayasingam, Arunasingam; Burnett, Deborah; Kelleher, Anthony; Brink, Robert; Bull, Rowena A.; Turville, Stuart; Stewar... Journal: MAbs Issue: Volume 13:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗